ROR-gamma-t inhibitors (Orca/AstraZeneca)

N/A

Report date: 2025/03/20 09:40:41
NME

Base Information

Drug NameROR-gamma-t inhibitors (Orca/AstraZeneca)
Drug Alias NameROR-gamma-t inhibitors (Orca Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor gamma inhibitors
TargetsRetinoic acid receptor gamma
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrca Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesOrca PharmaceuticalsAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A